Conclusions: Ferric carboxymaltose is an efficient and better alternative to Iron Sucrose in treating postpartum anemia. It has an added advantage of single dose regime with lower side effects.
What is the difference between feraheme and Injectafer?
Since Injectafer provides a greater amount of elemental iron and also increases hemoglobin more than Feraheme, a lower dose of Injectafer might help provide good efficacy with decreased adverse effects. Further research is warranted to test for adverse effects, such as severe hypophosphatemia.
What is the difference between Venofer and Ferrlecit?
High doses of iron sucrose (Venofer® at a dose of 250 mg/month) was equally effective in maintaining haemoglobin and equally well tolerated as low doses of iron gluconate (Ferrlecit® at a dose of 62.5 mg once per week) in stable, rHuEpo treated haemodialysis patients.
Is iron dextran same as iron sucrose?
Intravenous (IV) iron is an alternative treatment for patients intolerant or non-responsive to oral formulations. Of the two most common formulations available in Canada, IV iron dextran is less expensive but may be associated with more overall ADRs compared to IV iron sucrose.
Is ferric Carboxymaltose safe in pregnancy?
No adverse fetal or neonatal outcomes were observed. Conclusions: Ferric carboxymaltose infusion corrects iron deficiency or various degrees of iron deficiency anemia efficaciously and safely pregnant women, and does not cause hemoconcentration.
How do you administer ferric Carboxymaltose?
It is usually given as 2 doses, at least 7 days apart. It is usually given slowly over several minutes. It can also be mixed in a saline solution and given by infusion into a vein over at least 15 minutes. The dosage is based on your medical condition, weight, and response to treatment.
Is feraheme better than Venofer?
In a non-inferiority study, FERAHEME demonstrated comparable efficacy with Venofer® (iron sucrose) in iron deficiency anemia patients with chronic kidney disease (CKD) Error bars represent 95% CI.
Will iron infusion raise ferritin?
Parenteral iron Intravenous infusion results in a rapid replenishment of iron stores with peak ferritin concentrations at 7–9 days after infusion. In our experience the haemoglobin should rise within 2–3 weeks in the majority of patients.
Is Injectafer better than venofer?
Data showed that two 750 mg doses of Injectafer raised hemoglobin more than five 200mg doses of Venofer, with a change in hemoglobin of 1.13 g/dL for Injectafer vs. 0.92 for Venofer. These increases were statistically significant (treatment difference = 0.2).
What is the best tolerated iron supplement?
Conclusion: Extended-release ferrous sulfate with mucoproteose appears to be the best tolerated of the different oral iron supplements evaluated.
What is the most common side effect of iron sucrose?
Muscle cramps, nausea, vomiting, strange taste in the mouth, diarrhea, constipation, headache, cough, back pain, joint pain, dizziness, or swelling of the arms/legs may occur. Pain, swelling, or redness at the injection site may occur. If these effects continue or worsen, tell your doctor.
Is iron dextran safe?
Iron dextran can cause severe and sometimes fatal allergic reactions or severely low blood pressure. Tell your caregiver right away if you feel light-headed (like you might pass out), or if you suddenly have trouble breathing.
What is extravasation in injections?
Keywords: Extravasation, Antidotes, Intravenous injections, Patient care, Risk factors Introduction Extravasation refers to the leakage of injected drugs from blood vessels causing damage to the surrounding tissues.
How do you stop IV fluids after extravasation?
At the first sign of extravasation, nursing intervention with following steps is recommended: stop administration of IV fluids immediately, disconnect the IV tube from the cannula, aspirate any remaining drug from the cannula, administer drug-specific antidote, and notify the physician.
What are the long-term effects of extravasation?
In severe cases, extravasation may cause tissue dysfunction or physical defects, resulting in a delay of attempted treatment, patients’ distrust, and numerous other issues.
